Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry K Keefer

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Genomics|April 8, 2009
Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cellsJie Liu, Swati Malavya, Xueqian Wang, et al.
Redox Biology|September 12, 2013
Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balanceAnna E Maciag, Ryan J Holland, Y-S Robert Cheng, et al.
Neurosurgery|August 19, 2011
JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomasAstrid Weyerbrock, Nadja Osterberg, Nikolaos Psarras, et al.
Molecular Pharmaceutics|December 17, 2009
Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticlesVarun Kumar, Sam Y Hong, Anna E Maciag, et al.
ACS Medicinal Chemistry Letters|January 8, 2011
The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of ProlineSam Y Hong, Gregory L Borchert, Anna E Maciag, et al.
Molecular Pharmacology|November 17, 2005
A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteinsDanyelle M Townsend, Victoria J Findlay, Farit Fazilev, et al.
Journal of Vascular Surgery|March 13, 2010
Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injuryNick D Tsihlis, Jozef Murar, Muneera R Kapadia, et al.
Bioorganic & Medicinal Chemistry|April 7, 2012
Structural modifications modulate stability of glutathione-activated arylated diazeniumdiolate prodrugsRahul S Nandurdikar, Anna E Maciag, Ryan J Holland, et al.
Nitric Oxide : Biology and Chemistry|February 2, 2013
Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRIClaudia Weidensteiner, Wilfried Reichardt, Paul J Shami, et al.
Molecular Pharmacology|April 23, 2004
Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrugVictoria J Findlay, Danyelle M Townsend, Joseph E Saavedra, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Genomics|April 8, 2009
Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cellsJie Liu, Swati Malavya, Xueqian Wang, et al.
Redox Biology|September 12, 2013
Nitric oxide-releasing prodrug triggers cancer cell death through deregulation of cellular redox balanceAnna E Maciag, Ryan J Holland, Y-S Robert Cheng, et al.
Neurosurgery|August 19, 2011
JS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomasAstrid Weyerbrock, Nadja Osterberg, Nikolaos Psarras, et al.
Molecular Pharmaceutics|December 17, 2009
Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticlesVarun Kumar, Sam Y Hong, Anna E Maciag, et al.
ACS Medicinal Chemistry Letters|January 8, 2011
The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of ProlineSam Y Hong, Gregory L Borchert, Anna E Maciag, et al.
Molecular Pharmacology|November 17, 2005
A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteinsDanyelle M Townsend, Victoria J Findlay, Farit Fazilev, et al.
Journal of Vascular Surgery|March 13, 2010
Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injuryNick D Tsihlis, Jozef Murar, Muneera R Kapadia, et al.
Bioorganic & Medicinal Chemistry|April 7, 2012
Structural modifications modulate stability of glutathione-activated arylated diazeniumdiolate prodrugsRahul S Nandurdikar, Anna E Maciag, Ryan J Holland, et al.
Nitric Oxide : Biology and Chemistry|February 2, 2013
Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRIClaudia Weidensteiner, Wilfried Reichardt, Paul J Shami, et al.
Molecular Pharmacology|April 23, 2004
Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrugVictoria J Findlay, Danyelle M Townsend, Joseph E Saavedra, et al.
Pageof 12